ArticleJournal for immunotherapy of cancer2025
Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism?
Gianluca Azzellino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.